Chang David D
President And CEO
1 company
Insider Signal Score
56
GoodTrades Analyzed
4
12M Win Rate
50.0%
Avg 3M Return
+13.1%
Avg 12M Return
+19.9%
Chang David D is a President And CEO at Allogene Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 6 sells.
Estimated insider holdings value: $10.4M based on current market prices.
Holdings by Company
ALLOMar 14, 2025
Current Shares5.28M
Value$10.39M
Net Activity-117,167
Bought: 40.0KSold: 157.2K
Transaction History
Showing 6 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 46,668 | $1.96 | $91,469.28 | -0.9% | -27.8% | +23.7% | |
| Feb 3, 2025 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 46,003 | $1.68 | $77,285.04 | -0.9% | -3.0% | +4.2% | |
| Mar 15, 2022 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 23,648 | $7.65 | $180,878.82 | -1.0% | +13.5% | -27.4% | |
| Mar 15, 2021 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 20,513 | $38.57 | $791,270.51 | -0.9% | -35.0% | -80.0% | |
| Mar 16, 2020 | ALLO Allogene Therapeutics, Inc. | President And CEO | Sell | 20,335 | $19.31 | $392,615.23 | -0.5% | - | - | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | President And CEO | Buy | 40,000 | $18.00 | $720,000.00 | +2.0% | - | - |